7-[(Chlorocarbonyl)methoxy]-4-methylcoumarin 1 has been under development in LPC for the fluorescent labeling of primary and secondary hydroxyl groups. We have developed synthetic procedures which allow the gram-scale production of 1 in high purity, and we have found this reagent to react smoothly with a variety of primary and secondary hydroxyl compounds to give the corresponding esters. These esters readily elute from reversed- phase HPLC columns, thereby allowing detection by standard methods such as UV, fluorescence, or mass spectrometry. However, a small, but highly fluorescent impurity was discovered, isolated, and subsequently identified. The origin of this impurity was traced to a side-reaction of 7-(carboxymethoxy)-4-methylcoumarin with thionyl chloride, leading us to a new, coumarin-based, acylation reagent, 3-chloro-7- [(chlorocarbonyl)methoxy]-4-methyl-coumarin. We have developed synthetic procedures which now allow the gram-scale production of this new reagent. This new reagent provides a fluorophore which is many times more fluorescent than the corresponding non-chlorinated analog, thus lowering the limit of detection in potential applications. Upon derivatizing compounds which possess a hydroxyl moiety, we find the reactivity and selectivity of this new reagent similar to that of 7- [(chlorocarbonyl)methoxy]-4-methylcoumarin; the resulting derivatives also readily elute from reversed-phase HPLC columns, thereby allowing for facile analysis.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Intramural Research (Z01)
Project #
1Z01CM007352-02
Application #
3752450
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
2
Fiscal Year
1994
Total Cost
Indirect Cost
Name
Division of Cancer Treatment
Department
Type
DUNS #
City
State
Country
United States
Zip Code